ginsenoside-rg3 has been researched along with Stress-Disorders--Post-Traumatic* in 1 studies
1 other study(ies) available for ginsenoside-rg3 and Stress-Disorders--Post-Traumatic
Article | Year |
---|---|
Ginsenoside Rg3 modulates spatial memory and fear memory extinction by the HPA axis and BDNF-TrkB pathway in a rat post-traumatic stress disorder.
Post-traumatic stress disorder (PTSD) is a serious mental disorder that can develop after exposure to extreme stress. Korean red ginseng, whose major active component is ginsenoside Rg3 (Rg3), is a widely used traditional antioxidant that has anti-inflammatory, anti-apoptotic and anxiolytics effects. This study investigated whether the administration of Rg3 ameliorated the memory deficit induced by a single prolonged stress (SPS) in rats. Male rats were dosed with Rg3 (25 or 50 mg/kg) once daily for 14 days after exposure to SPS. Rg3 administration improved fear memory and spatial memory might be involved in modulating the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and monoamine imbalance in the medial prefrontal cortex and hippocampus. It also increased the reduction in the brain-derived neurotrophic factor (BDNF) and tropomyosin-related kinase B (TrkB) mRNAs expression, and the ratio of p-Akt/Akt in the hippocampus. Thus, Rg3 exerted memory-improving actions might be involved in regulating HPA axis and activating BDNF-TrkB pathway. Our findings suggest that Rg3 could be useful for preventing traumatic stress, such as PTSD. Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Fear; Ginsenosides; Hippocampus; Humans; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Proto-Oncogene Proteins c-akt; Rats; Spatial Memory; Stress Disorders, Post-Traumatic | 2022 |